Kathrin Kahnert
About
Kathrin Kahnert is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology.
According to data from OpenAlex, Kathrin Kahnert has authored 95 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 30 papers in Physiology and 23 papers in Oncology. Recurrent topics in Kathrin Kahnert's work include Chronic Obstructive Pulmonary Disease (COPD) Research (52 papers), Respiratory Support and Mechanisms (23 papers) and Asthma and respiratory diseases (23 papers). Kathrin Kahnert is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (52 papers), Respiratory Support and Mechanisms (23 papers) and Asthma and respiratory diseases (23 papers). Kathrin Kahnert collaborates with scholars based in Germany, Netherlands and Austria. Kathrin Kahnert's co-authors include Rudolf A. Jörres, Jürgen Behr, Diego Kauffmann‐Guerrero, Tobias Welte, Rudolf M. Huber, Claus Vogelmeier, Peter Alter, Robert Bals, Henrik Watz and Amanda Tufman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
In The Last Decade
Kathrin Kahnert
77 papers receiving 847 citations
Peers
Kathrin Kahnert
Shawn Nishi United States
Teppei Okamoto Japan
Geoffrey W.B. Clark United Kingdom
D. Yin United States
Markus Roeßler Germany
Niharika Samala United States
Wassim W. Labaki United States
Xuezhong Shi China
Kenneth J. Vega United States
John D. Maclay United Kingdom
Citations per year, relative to Kathrin Kahnert Kathrin Kahnert (= 1×)
peers
Shawn Nishi
Countries citing papers authored by Kathrin Kahnert
Since
Specialization
Citations
This map shows the geographic impact of Kathrin Kahnert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Kahnert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Kahnert more than expected).
Fields of papers citing papers by Kathrin Kahnert
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kathrin Kahnert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Kahnert. The network helps show where Kathrin Kahnert may publish in the future.
Co-authorship network of co-authors of Kathrin Kahnert
This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Kahnert. A scholar is included among the top collaborators of Kathrin Kahnert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Kahnert. Kathrin Kahnert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Jörres, Rudolf A., et al.. (2024). Period of hospitalization and mortality in transferred versus non-transferred COVID-19 patients: results from Germany. Scientific Reports. 14(1). 7338–7338.
2.
Fischer, Christian, Rudolf A. Jörres, Stefan Engelhardt, et al.. (2024). Characteristics and outcomes of patients hospitalized for infection with Influenza A, SARS-CoV-2 or respiratory syncytial virus in the season 2023/2024 in a large German primary care centre. European journal of medical research. 29(1). 509–509.
3.
Melzer, Thomas, Stefan Karrasch, Claus Vogelmeier, et al.. (2024). Skin Markers of Premature Ageing in Patients with COPD: Results Form COSYCONET. Journal of Clinical Medicine. 13(22). 6972–6972.
4.
Stoleriu, Mircea Gabriel, Michael Pienn, Peter Alter, et al.. (2024). Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET. International Journal of COPD. Volume 19. 1515–1529.
5.
Alter, Peter, Kathrin Kahnert, Franziska Trudzinski, et al.. (2024). Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET. International Journal of COPD. Volume 19. 2629–2638.
6.
Fischer, Elke Kerstin, Kathrin Kahnert, Oliver Pogarell, et al.. (2024). Implications of Switching from Conventional to Electronic Cigarettes on Quality of Life and Smoking Behaviour: Results from the EQualLife Trial. European Addiction Research. 30(4). 207–215.
7.
Kahnert, Kathrin, et al.. (2023). Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing. Therapeutic Advances in Respiratory Disease. 17. 2683778998–2683778998.
8.
Ghiani, Alessandro, et al.. (2023). Ventilatory ratio and mechanical power in prolonged mechanically ventilated COVID-19 patients versus respiratory failures of other etiologies. Therapeutic Advances in Respiratory Disease. 17. 2683735072–2683735072.
9.
Kahnert, Kathrin, Rudolf A. Jörres, Hans‐Ulrich Kauczor, et al.. (2023). Standardized airway wall thickness Pi10 from routine CT scans of COPD patients as imaging biomarker for disease severity, lung function decline, and mortality. Therapeutic Advances in Respiratory Disease. 17. 2673727991–2673727991.
10.
Alter, Peter, Kathrin Kahnert, Franziska Trudzinski, et al.. (2023). Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort. Therapeutic Advances in Respiratory Disease. 17. 2683787912–2683787912.
11.
Nakayama, Misako, Juliane Merl‐Pham, Elisabeth Hennen, et al.. (2023). Quantitative proteomics of differentiated primary bronchial epithelial cells from chronic obstructive pulmonary disease and control identifies potential novel host factors post-influenza A virus infection. Frontiers in Microbiology. 13. 957830–957830.
12.
Walter, Julia, Diego Kauffmann‐Guerrero, Thomas Muley, et al.. (2023). Comparison of the sensitivity of different criteria to select lung cancer patients for screening in a cohort of German patients. Cancer Medicine. 12(7). 8880–8896.
13.
Jörres, Rudolf A., et al.. (2023). Retrospektive klinisch-kausale Bewertung einer positiven PCR für SARS-CoV-2 bei hospitalisierten Patienten des gesamten Altersspektrums in einem Krankenhaus der Schwerpunktversorgung. Pneumologie. 78(2). 100–106.
14.
Alter, Peter, Kathrin Kahnert, Franziska Trudzinski, et al.. (2022). Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET. International Journal of COPD. Volume 17. 1703–1713.
15.
Alter, Peter, Henrik Watz, Stefan Andreas, et al.. (2022). Cardiovascular predictors of mortality and exacerbations in patients with COPD. Scientific Reports. 12(1). 21882–21882.
16.
Tufman, Amanda, Jens Neumann, Farkhad Manapov, et al.. (2021). Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT). Lung Cancer. 160. 17–27.
17.
Welte, Tobias, Henrik Watz, Benjamin Waschki, et al.. (2020). Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort. SHILAP Revista de lepidopterología.
18.
Lutter, Johanna I., Rudolf A. Jörres, Tobias Welte, et al.. (2020). <p>Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort</p>. International Journal of COPD. Volume 15. 2787–2798.
19.
Jörres, Rudolf A., Jürgen Behr, Peter Alter, et al.. (2019). Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study. Respiratory Research. 20(1). 30–30.
20.
Kauffmann‐Guerrero, Diego, Kathrin Kahnert, Jörg Kumbrink, et al.. (2018). Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib. Clinical Lung Cancer. 20(1). 59–62.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Shawn Nishi Breakdown of academic impact, for papers by Teppei Okamoto Breakdown of academic impact, for papers by Geoffrey W.B. Clark Breakdown of academic impact, for papers by D. Yin Breakdown of academic impact, for papers by Markus Roeßler Breakdown of academic impact, for papers by Niharika Samala Breakdown of academic impact, for papers by Wassim W. Labaki Breakdown of academic impact, for papers by Xuezhong Shi Breakdown of academic impact, for papers by Kenneth J. Vega Breakdown of academic impact, for papers by John D. Maclay